PUBLIC COMPANY
save$IMNMImmunome Inc.
$IMNM26.42-5.61%Bothell, WA, USupdated 5h ago
The immunome is the set of genes that code for proteins which constitute the immune system, excluding those that are widespread in other cell types, and not involved in the immune response itself. It is further defined as the set of peptides derived from the proteome that interact with the immune system. There are numerous ongoing efforts to characterize and sequence the immunomes of humans, mice, and elements of non-human primates.
community read0 votes
pipeline
3
marketed
0
phase 3
1
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
2Phase 11Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
view all catalysts →Insider activity
source: SEC Form 4open-market buys + sells
- Apr 2, 26SELLRosett Max· Chief Financial Officer−$1.39M↗
- Apr 2, 26SELLHiggins Jack· Chief Scientific Officer−$204K↗
- Apr 2, 26SELLRosett Max· Chief Financial Officer−$30K↗
- Mar 27, 26BUYSIEGALL CLAY B· President and CEO$501K↗
- Mar 23, 26SELLWAGENHEIM PHILIP· −$582K↗
- Mar 20, 26SELLWAGENHEIM PHILIP· −$753K↗
- Mar 11, 26BUYBIENAIME JEAN JACQUES· $22K↗
- Mar 10, 26BUYBIENAIME JEAN JACQUES· $22K↗
routine RSU / option mechanics (5)
- Apr 2, 26option exerciseRosett Max · Chief Financial Officer39,713 sh
- Apr 2, 26option exerciseRosett Max · Chief Financial Officer31,848 sh
- Apr 2, 26option exerciseRosett Max · Chief Financial Officer39,713 sh
- Apr 2, 26option exerciseRosett Max · Chief Financial Officer31,848 sh
- Mar 30, 26giftHiggins Jack · Chief Scientific Officer6,291 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 25m ago
Found something off?
comments(0)
5-min edit window · permanent after that